Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 26.04
-0.56 (-2.11%)
Dec 10, 2025, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 10.57 billion as of December 10, 2025. Its market cap has increased by 138.24% in one year.
Market Cap
10.57B
Enterprise Value
10.76B
Revenue
709.13M
Ranking
n/a
PE Ratio
164.05
Stock Price
26.04
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 10.57B, a decrease of -34.63%. That is a compound annual growth rate of -9.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 10.57B | 145.66% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 414.65B |
| WuXi AppTec | 272.61B |
| Shenzhen Mindray Bio-Medical Electronics | 241.94B |
| Sichuan Biokin Pharmaceutical | 149.08B |
| Shanghai United Imaging Healthcare | 106.37B |
| Aier Eye Hospital Group | 105.97B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.17B |
| Yunnan Baiyao Group Co.,Ltd | 100.10B |